Pharmaceuticals News and Research

RSS
SmartTots sets agenda for research on anesthetic safety in children

SmartTots sets agenda for research on anesthetic safety in children

2 Nov 2011
Takeda receives FDA approval for VELCADE sNDA to treat MM

Takeda receives FDA approval for VELCADE sNDA to treat MM

2 Nov 2011
Perrigo's partner receives final approval for Epinastine HCl ophthalmic solution

Perrigo's partner receives final approval for Epinastine HCl ophthalmic solution

2 Nov 2011
GSK, Alnylam collaborate to apply VaxiRNA technology for influenza vaccine production

GSK, Alnylam collaborate to apply VaxiRNA technology for influenza vaccine production

2 Nov 2011
Rigel reports net loss of $17.9 million for third quarter 2011

Rigel reports net loss of $17.9 million for third quarter 2011

1 Nov 2011
Watson third quarter net income increases 31% to $138.7 million

Watson third quarter net income increases 31% to $138.7 million

1 Nov 2011
Akorn third quarter consolidated revenue increases 69% to $36.7M

Akorn third quarter consolidated revenue increases 69% to $36.7M

1 Nov 2011
iBio receives U.S. patent entitled 'System for Expression of Genes in Plants'

iBio receives U.S. patent entitled 'System for Expression of Genes in Plants'

1 Nov 2011
NPS announces new data from GATTEX Phase 3 study on short bowel syndrome

NPS announces new data from GATTEX Phase 3 study on short bowel syndrome

1 Nov 2011
Teva reports data from QNASL studies on seasonal and perennial allergic rhinitis

Teva reports data from QNASL studies on seasonal and perennial allergic rhinitis

1 Nov 2011
UCB to present new data on Cimzia at ACG annual scientific meeting

UCB to present new data on Cimzia at ACG annual scientific meeting

1 Nov 2011
Initiation of two IPI-145 Phase 1 clinical trials triggers $4M milestone payment to Intellikine

Initiation of two IPI-145 Phase 1 clinical trials triggers $4M milestone payment to Intellikine

31 Oct 2011
J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

31 Oct 2011
Infinity commences two IPI-145 Phase 1 clinical trials for hematologic malignancies

Infinity commences two IPI-145 Phase 1 clinical trials for hematologic malignancies

31 Oct 2011
Positive initial results from CytRx's INNO-206 Phase 1b/2 clinical trial for advanced solid tumors

Positive initial results from CytRx's INNO-206 Phase 1b/2 clinical trial for advanced solid tumors

31 Oct 2011
Avanir seeks EMA marketing authorization for NUEDEXTA to treat pseudobulbar affect

Avanir seeks EMA marketing authorization for NUEDEXTA to treat pseudobulbar affect

31 Oct 2011
Auxilium reports net revenues of $66.7 million for third quarter 2011

Auxilium reports net revenues of $66.7 million for third quarter 2011

31 Oct 2011
GC-C agonists have potential to delay progression of colitis into colon cancer

GC-C agonists have potential to delay progression of colitis into colon cancer

31 Oct 2011
Pacira's third quarter total revenues decrease to $4.0 million

Pacira's third quarter total revenues decrease to $4.0 million

31 Oct 2011
Astex to present data on direct acting antiviral agents against HCV at 62nd AASLD meeting

Astex to present data on direct acting antiviral agents against HCV at 62nd AASLD meeting

31 Oct 2011

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback